Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001647566-15-000002
Filing Date
2015-07-09
Accepted
2015-07-09 17:10:20
Documents
3
Period of Report
2015-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_143647620968823.html 3  
1 FORM 3 wf-form3_143647620968823.xml 3 1704
2 SHAKNOVICH POA shaknovichpoa7815.htm EX-24 617
3 SHAKNOVICH POA shaknovichpoa7815001.jpg GRAPHIC 191867
  Complete submission text file 0001647566-15-000002.txt   268307
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Issuer) CIK: 0001349929 (see all company filings)

EIN.: 043462475 | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O CANCER GENETICS, INC. 201 ROUTE 17N 2ND FLOOR RUTHERFORD NJ 07070
Business Address
Shaknovich Rita (Reporting) CIK: 0001647566 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35817 | Film No.: 15982008